Cidara Therapeutics Total Assets 2014-2022 | CDTX

Cidara Therapeutics total assets from 2014 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cidara Therapeutics Annual Total Assets
(Millions of US $)
2021 $75
2020 $60
2019 $69
2018 $79
2017 $79
2016 $107
2015 $110
2014 $24
2013 $0
Cidara Therapeutics Quarterly Total Assets
(Millions of US $)
2022-03-31 $55
2021-12-31 $75
2021-09-30 $51
2021-06-30 $64
2021-03-31 $54
2020-12-31 $60
2020-09-30 $64
2020-06-30 $73
2020-03-31 $84
2019-12-31 $69
2019-09-30 $82
2019-06-30 $52
2019-03-31 $64
2018-12-31 $79
2018-09-30 $93
2018-06-30 $107
2018-03-31 $70
2017-12-31 $79
2017-09-30 $67
2017-06-30 $81
2017-03-31 $93
2016-12-31 $107
2016-09-30 $82
2016-06-30 $90
2016-03-31 $99
2015-12-31 $110
2015-09-30 $117
2015-06-30 $124
2015-03-31 $61
2014-12-31 $24
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.030B $0.050B
Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00